The effect of rituximab on the quality of life of children with refractory nephrotic syndrome.
Takahashi T, Okamoto T, Yokota I, Sato Y, Hayashi A, Ueda Y, Aoyagi H, Ueno M, Kobayashi N, Uetake K, Nakanishi M, Ariga T.
Takahashi T, et al. Among authors: ueda y.
Pediatr Int. 2022 Jan;64(1):e14725. doi: 10.1111/ped.14725. Epub 2021 Dec 2.
Pediatr Int. 2022.
PMID: 33826766